PROVIDER PROFILE · NPI 1033443551
Sagarika RayMD
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
12
Beneficiaries
—
Total drug cost
$1K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Olanzapine12 claims
QUALITY · MIPS · 2024
Final MIPS score
86.5
Quality
57.3
Cost
80.2
Improvement activities
40.0
Promoting interop.
84.0
Payment adjustment
0.48%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE